Hydroxyzine pamoate, 50 mg, oral, fda approved prescription anti-emetic, for chemotherapy treatment, not to exceed a 48 hour dosage regimen use as a complete therapeutic substitute for an iv anti-emetic at the time of
This is the 2006 version of HCPCS Q0178 - please refer to the 2016 HCPCS code set for the latest version.
Added on Wednesday, April 01, 1998
Status changed on Wednesday, April 01, 1998 to: No maintenance for this code
BETOS Classification: Chemotherapy
Medicare coverage status: Special coverage instructions apply
